Vesper Bio ApS
32879861ActiveA clinical-stage biotech company developing oral therapies for neurodegeneration.
Overview
- 7
- Employees
- Unknown
- Revenue
- 2010
- Founded
Key Decision Makers
Anders Nykjær
Founder
Jacob Falck Hansen
Chief Executive Officer
John King-Underwood
Medicinal Chemistry
Graham Wynne
Medicinal Chemistry
+1 more contacts in Funnelfeedr
Description
Vesper Bio is a clinical-stage biotechnology company dedicated to pioneering research in Sortilin biology. The organization focuses on developing innovative oral therapies for patients suffering from devastating and fatal disorders, specifically targeting Frontotemporal Degeneration. Founded on deep...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Unknown
- Legal Form
- APS
- VAT Number
- DK32879861
Decision Makers
5 contacts in FunnelfeedrAnders Nykjær
Founder
Jacob Falck Hansen
Chief Executive Officer
Other Contacts
John King-Underwood
Medicinal Chemistry
Graham Wynne
Medicinal Chemistry
Andy Mulvaney
Business Development
Similar Companies
20 similar companies in FunnelfeedrNeumirna Therapeutics ApS
9 employeesDeveloping miRNA-based therapies to treat complex neurological disease root causes.
CONTERA PHARMA A/S
19 employeesDanish biotech company developing innovative RNA therapeutics for neurological disorders.
Vertanical Denmark ApS
23 employeesInnovative biopharmaceutical company developing advanced cannabinoid-based chronic pain therapies.
Pephexia Therapeutics ApS
5 employeesDeveloping innovative peptide-based therapies for treating cachexia and sarcopenia.
PAREXEL DENMARK A/S
20 employeesLeading global clinical research organization accelerating life-changing medical treatments worldwide.
Browse More
Vesper Bio ApS Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo